跳转至内容
Merck
CN

SML2424

Terlipressin acetate salt

≥95% (HPLC)

别名:

H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-GlyNH2 acetate salt (Disulfide bond), N-(glycylglycylglycyl)-8-L-lysine-vasopressin acetate salt

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C52H74N16O15S2 · xC2H4O2
化学文摘社编号:
914453-96-6
分子量:
1227.37 (free base basis)
UNSPSC Code:
12352200
NACRES:
NA.77

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

assay

≥95% (HPLC)

SMILES string

S1SC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C1)C(=O)N4[C@@H](CCC4)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N)Cc3ccccc3)Cc2ccc(cc2)O)NC(=O)CNC(=O)CNC(=O)CN.OC(=O)C.OC(=O)C

InChI

1S/C52H74N16O15S2.2C2H4O2/c53-17-5-4-9-31(45(76)60-23-41(57)72)63-51(82)38-10-6-18-68(38)52(83)37-27-85-84-26-36(61-44(75)25-59-43(74)24-58-42(73)22-54)50(81)65-34(20-29-11-13-30(69)14-12-29)48(79)64-33(19-28-7-2-1-3-8-28)47(78)62-32(15-16-39(55)70)46(77)66-35(21-40(56)71)49(80)67-37;2*1-2(3)4/h1-3,7-8,11-14,31-38,69H,4-6,9-10,15-27,53-54H2,(H2,55,70)(H2,56,71)(H2,57,72)(H,58,73)(H,59,74)(H,60,76)(H,61,75)(H,62,78)(H,63,82)(H,64,79)(H,65,81)(H,66,77)(H,67,80);2*1H3,(H,3,4)/t31-,32-,33-,34-,35-,36-,37-,38-;;/m0../s1

InChI key

WNFVFDPQEHRNTC-LWCZBKQBSA-N

form

lyophilized powder

storage condition

desiccated

color

white

shipped in

wet ice

storage temp.

−20°C

相关类别

Biochem/physiol Actions

Synthetic vasopressin analog and agonist
Terlipressin is a synthetic vasopressin analog and agonist. It has been used as a vasoactive drug for treatment of Hepatorenal syndrome in cirrhosis of the liver.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000494348
0000494348
0000484859
0000484859
0000059360

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Timothy Papaluca et al.
Journal of gastroenterology and hepatology, 33(3), 591-598 (2017-10-06)
Terlipressin is an analogue of vasopressin that has potent vasoactive properties and has been available for use in most countries for nearly two decades. It has both established roles and emerging indications in the management of complications of decompensated chronic
Tim G Kampmeier et al.
Scientific reports, 8(1), 7105-7105 (2018-05-10)
The Surviving Sepsis Guidelines suggest the use of vasopressin in case of catecholamine-refractory septic shock. Terlipressin (TP) as a V1-selective AVP analogue is a potential alternative, though data regarding the first-line administration in septic shock are scarce. The present study
K K Ida et al.
British journal of anaesthesia, 120(6), 1245-1254 (2018-05-26)
During early treatment of haemorrhagic shock, cerebral perfusion pressure can be restored by small-volume resuscitation with vasopressors. Whether this therapy is improved with additional fluid remains unknown. We assessed the value of terlipressin and lactated Ringer's solution (LR) on early

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持